Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Barboriak

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|February 13, 2023
Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625Jerrold L Boxerman, Bradley S Snyder, Daniel P Barboriak, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 28, 2008
Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imagingDaniel P Barboriak, James R MacFall, Benjamin L Viglianti, et al.
AJR. American Journal of Roentgenology|March 22, 2008
Hippocampal MRI signal hyperintensity after febrile status epilepticus is predictive of subsequent mesial temporal sclerosisJames M Provenzale, Daniel P Barboriak, Kevan VanLandingham, et al.
Magnetic Resonance in Medicine|May 1, 2010
An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumabGregory Z Ferl, Lu Xu, Michel Friesenhahn, et al.
Radiology|March 31, 2005
Assessment of apparent diffusion coefficient in normal and degenerated intervertebral lumbar disks: initial experienceSusan M Kealey, Todd Aho, David Delong, et al.
Neuro-Oncology|July 18, 2020
Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trialKathleen M Schmainda, Melissa A Prah, Helga Marques, et al.
Progress in Brain Research|July 30, 2002
Do prolonged febrile seizures produce medial temporal sclerosis? Hypotheses, MRI evidence and unanswered questionsDarrell V Lewis, Daniel P Barboriak, James R MacFall, et al.
Magnetic Resonance in Medicine|July 29, 2010
Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumabRuediger E Port, Lisa J Bernstein, Daniel P Barboriak, et al.
Academic Radiology|February 23, 2016
Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile ClaimsNancy A Obuchowski, Andrew Buckler, Paul Kinahan, et al.
Psychiatry Research|July 13, 2002
MR signal intensity of gray matter/white matter contrast and intracranial fat: effects of age and sexDennis M Kim, Stavra A Xanthakos, Larry A Tupler, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|February 13, 2023
Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625Jerrold L Boxerman, Bradley S Snyder, Daniel P Barboriak, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 28, 2008
Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imagingDaniel P Barboriak, James R MacFall, Benjamin L Viglianti, et al.
AJR. American Journal of Roentgenology|March 22, 2008
Hippocampal MRI signal hyperintensity after febrile status epilepticus is predictive of subsequent mesial temporal sclerosisJames M Provenzale, Daniel P Barboriak, Kevan VanLandingham, et al.
Magnetic Resonance in Medicine|May 1, 2010
An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumabGregory Z Ferl, Lu Xu, Michel Friesenhahn, et al.
Radiology|March 31, 2005
Assessment of apparent diffusion coefficient in normal and degenerated intervertebral lumbar disks: initial experienceSusan M Kealey, Todd Aho, David Delong, et al.
Neuro-Oncology|July 18, 2020
Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trialKathleen M Schmainda, Melissa A Prah, Helga Marques, et al.
Progress in Brain Research|July 30, 2002
Do prolonged febrile seizures produce medial temporal sclerosis? Hypotheses, MRI evidence and unanswered questionsDarrell V Lewis, Daniel P Barboriak, James R MacFall, et al.
Magnetic Resonance in Medicine|July 29, 2010
Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumabRuediger E Port, Lisa J Bernstein, Daniel P Barboriak, et al.
Academic Radiology|February 23, 2016
Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile ClaimsNancy A Obuchowski, Andrew Buckler, Paul Kinahan, et al.
Psychiatry Research|July 13, 2002
MR signal intensity of gray matter/white matter contrast and intracranial fat: effects of age and sexDennis M Kim, Stavra A Xanthakos, Larry A Tupler, et al.
Pageof 5